News >

Making Headway in Hematologic Cancer Research at UCLA

Kristi Rosa
Published: Tuesday, Oct 08, 2019

During the 2019 OncLive® State of the Science Summit™ on Hematologic Malignancies in Beverly Hills, California, we spoke with leading oncology experts at the University of California, Los Angeles (UCLA) on the pivotal research being conducted at their institution.

 
Gary J. Schiller, MD, irector of hematologic malignancies in the Stem Cell Transplant Unit in the David Geffen School of Medicine at University of California, Los Angeles

Gary J. Schiller, MD

Gary J. Schiller, MD

Director, Hematologic Malignancies Stem Cell Transplant Unit at the David Geffen School of Medicine, UCLA

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 3rd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesNov 29, 20192.0
Advances in™ ALL: The Role of T-Cell Engaging Immunotherapy in Treating Relapsed DiseaseNov 30, 20191.0
Publication Bottom Border
Border Publication
x